SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

Neurotrophic Factor Therapy for Neurodegeneration

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-neurotrophic-factor-th
Related Entities
therapeutics-neurotrophic-factor-therapy-neurodegeneration
Metadata
slugtherapeutics-neurotrophic-factor-therapy-neurodegeneration
entity_typetherapeutic
kg_node_idNone
Linked Artifacts (948)
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Temporal Decoupling via Circadian Clock Reset80%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination80%
related🧪Netrin-1 Gradient Restoration80%
related🧪Smartphone-Detected Motor Variability Correction80%
related🧪Purinergic Signaling Polarization Control80%
related🧪Mitochondrial-Lysosomal Contact Site Engineering80%
related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 80%
related🧪Circadian-Synchronized Proteostasis Enhancement80%
related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration80%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement80%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer80%
related🧪Ganglioside Rebalancing Therapy80%
related🧪Mitochondrial SPM Synthesis Platform Engineering80%
related🧪CX43 hemichannel engineering enables size-selective mitochon80%
related🧪Arginine Methylation Enhancement Therapy80%
related🧪Senescent Cell Mitochondrial DNA Release80%
related🧪SASP-Mediated Cholinergic Synapse Disruption80%
related🧪Mitochondrial RNA Granule Rescue Pathway80%
related🧪Multi-Modal Stress Response Harmonization80%
related🧪Complement C1q Mimetic Decoy Therapy80%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu80%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc80%
related🧪CYP46A1 Overexpression Gene Therapy80%
related🧪Enteric Nervous System Prion-Like Propagation Blockade80%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m80%
related🧪Retinal Vascular Microcirculation Rescue80%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition80%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho80%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation80%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi80%
related🧪Noradrenergic-Tau Propagation Blockade80%
related🧪Adenosine-Astrocyte Metabolic Reset80%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho80%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones80%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors80%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists80%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations80%
related🧪Quantum Coherence Disruption in Cellular Communication80%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation80%
related🧪Cryptic Exon Silencing Restoration80%
related🧪SIRT6-NAD+ Axis Enhancement Therapy80%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics80%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes80%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem80%
related🧪SASP-Mediated Complement Cascade Amplification80%
related🧪Complement C1q Subtype Switching80%
related🧪Microglial Purinergic Reprogramming80%
related🧪Heat Shock Protein 70 Disaggregase Amplification80%
related🧪Autophagosome Maturation Checkpoint Control80%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener80%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal80%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement80%
related🧪Sphingolipid Metabolism Reprogramming80%
related🧪PARP1 Inhibition Therapy80%
related🧪Low Complexity Domain Cross-Linking Inhibition80%
related🧪Ocular Immune Privilege Extension80%
related🧪Hypocretin-Neurogenesis Coupling Therapy80%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation80%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu80%
related🧪Extracellular Matrix Stiffness Modulation80%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism80%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation80%
related🧪Perforant Path Presynaptic Terminal Protection Strategy80%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor80%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset80%
related🧪Senescence-Induced Lipid Peroxidation Spreading80%
related🧪Piezoelectric Nanochannel BBB Disruption80%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis80%
related🧪Lipid Droplet Dynamics as Phenotype Switches80%
related🧪Circadian-Synchronized LRP1 Pathway Activation80%
related🧪Glycine-Rich Domain Competitive Inhibition80%
related🧪SASP-Driven Aquaporin-4 Dysregulation80%
related🧪Axonal RNA Transport Reconstitution80%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In80%
related🧪Circadian-Gated Maresin Biosynthesis Amplification80%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming80%
related🧪Orexin-Microglia Modulation Therapy80%
related🧪KDM6A-Mediated H3K27me3 Rejuvenation80%
related🧪Lysosomal Membrane Repair Enhancement80%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement80%
related🧪Lysosomal Calcium Channel Modulation Therapy80%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue80%
related🧪Blood-Brain Barrier SPM Shuttle System80%
related🧪Mitochondrial Transfer Pathway Enhancement80%
related🧪Stress Granule Phase Separation Modulators80%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr80%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction80%
related🧪Pharmacological Enhancement of APOE4 Glycosylation80%
related🧪Membrane Cholesterol Gradient Modulators80%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto80%
related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu80%
related🧪Flotillin-1 Stabilization Compounds80%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization80%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy80%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling80%
related🧪HDAC3-Selective Inhibition for Clock Reset80%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering80%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati80%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th80%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation80%
related🧪Transcriptional Autophagy-Lysosome Coupling80%
related🧪Digital Twin-Guided Metabolic Reprogramming80%
related🧪Lysosomal Positioning Dynamics Modulation80%
related🧪Lysosomal Enzyme Trafficking Correction80%
related🧪Circadian Clock-Autophagy Synchronization80%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides80%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri80%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai80%
related🧪Senescence-Associated Myelin Lipid Remodeling80%
related🧪Glial Glycocalyx Remodeling Therapy80%
related🧪R-Loop Resolution Enhancement Therapy80%
related🧪Aquaporin-4 Polarization Rescue80%
related🧪Senescence-Activated NAD+ Depletion Rescue80%
related🧪Competitive APOE4 Domain Stabilization Peptides80%
related🧪Epigenetic Memory Erasure via TET2 Activation80%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol80%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy80%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy80%
related🧪Mechanosensitive Ion Channel Reprogramming80%
related🧪Serine/Arginine-Rich Protein Kinase Modulation80%
related🧪Selective Acid Sphingomyelinase Modulation Therapy80%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)80%
related🧪Vocal Cord Neuroplasticity Stimulation80%
related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme80%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors80%
related🧪Ephrin-B2/EphB4 Axis Manipulation80%
related🧪Microbial Inflammasome Priming Prevention80%
related🧪Phase-Separated Organelle Targeting80%
related🧪Nucleolar Stress Response Normalization80%
related🧪Vagal Afferent Microbial Signal Modulation80%
related🧪Cross-Seeding Prevention Strategy80%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution80%
related🧪Purinergic P2Y12 Inverse Agonist Therapy80%
related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection80%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat80%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch80%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming80%
related🧪Sphingomyelin Synthase Activators for Raft Remodeling80%
related🧪RNA Granule Nucleation Site Modulation80%
see_also📖Cell-Free DNA Biomarkers in Neurodegeneration80%
see_also📖Exosomal Biomarkers in Neurodegeneration80%
see_also📖Exosomal miR-155 in Neurodegeneration80%
see_also📖IL-6 (Interleukin-6) in Neurodegeneration80%
see_also📖Liquid Biopsy in Neurodegeneration80%
see_also📖Metabolomic Biomarkers in Neurodegeneration80%
see_also📖Neuroimaging Biomarkers for Neurodegeneration80%
see_also📖Synaptic Biomarkers in Neurodegeneration80%
see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and80%
see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl80%
see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 80%
see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)80%
see_also📖China Neurodegeneration Epidemiology80%
see_also📖DALY Methodology — Neurodegeneration80%
see_also📖Disease Progression & Staging in Neurodegeneration80%
see_also📖Economic Burden — Neurodegeneration80%
see_also📖European Neurodegeneration Epidemiology80%
see_also📖Familial vs Sporadic Neurodegeneration Comparison80%
see_also📖Global Neurodegeneration Epidemiology80%
see_also📖India Neurodegeneration Epidemiology80%
see_also📖Japan Neurodegeneration Epidemiology80%
see_also📖Manganese-Related Neurodegeneration (Manganism)80%
see_also📖mitochondrial-dysfunction-neurodegeneration-comparison80%
see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr80%
see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 80%
see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)80%
see_also📖Potential Impact Measures — Neurodegeneration80%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)80%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)80%
see_also📖PLA2G6-Associated Neurodegeneration (PLAN)80%
see_also📖Sleep Disorders in Neurodegeneration80%
see_also📖US Neurodegeneration Epidemiology80%
see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread80%
see_also📖acetylcholine-signaling-neurodegeneration80%
see_also📖Advanced Glycation End Products in Neurodegeneration80%
see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 80%
see_also📖Amylin Signaling in Neurodegeneration80%
see_also📖Antibody Therapy in Neurodegeneration80%
see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration80%
see_also📖Autosis Pathway in Neurodegeneration80%
see_also📖Axon Guidance Pathways in Neurodegeneration80%
see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration80%
see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain80%
see_also📖CaMKII Signaling Pathway in Neurodegeneration80%
see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration80%
see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration80%
see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration80%
see_also📖Cholinergic System Dysfunction in Neurodegeneration80%
see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat80%
see_also📖Neural Circuits in Neurodegeneration80%
see_also📖Cognitive Reserve and Resilience in Neurodegeneration80%
see_also📖Computational Disease Models for Neurodegeneration80%
see_also📖Convergent Pathways in Neurodegeneration80%
see_also📖Copper Homeostasis in Neurodegeneration80%
see_also📖COVID-19 Neurodegeneration Mechanism80%
see_also📖Diffusion MRI (DTI) in Neurodegeneration80%
see_also📖Digital Phenotyping in Neurodegeneration80%
see_also📖Down Syndrome Neurodegeneration Pathway80%
see_also📖Dystrophic Neurites in Neurodegeneration80%
see_also📖Endocannabinoid System in Neurodegeneration80%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration80%
see_also📖Endosomal Sorting Defects in Neurodegeneration80%
see_also📖Endothelin Signaling Pathway in Neurodegeneration80%
see_also📖epigenetics-neurodegeneration80%
see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration80%
see_also📖FA2H-Associated Neurodegeneration Pathway80%
see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration80%
see_also📖Galectin-3 Mechanism in Neurodegeneration80%
see_also📖Gangliosides in Neurodegeneration80%
see_also📖GDF15/GDF11 Signaling in Neurodegeneration80%
see_also📖GDNF Signaling Pathway in Neurodegeneration80%
see_also📖Ghrelin Signaling Pathway in Neurodegeneration80%
see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration80%
see_also📖Glycosylation in Neurodegeneration80%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration80%
see_also📖Hippocampal Neurogenesis in Neurodegeneration80%
see_also📖Histone Modification Pathways in Neurodegeneration80%
see_also📖HMGB1 Signaling in Neurodegeneration80%
see_also📖Homocysteine Neurotoxicity and Neurodegeneration80%
see_also📖IGF-1 Signaling Pathway in Neurodegeneration80%
see_also📖IL-1 Signaling Pathway in Neurodegeneration80%
see_also📖Integrated Stress Response in Neurodegeneration80%
see_also📖interleukin-6-signaling-neurodegeneration80%
see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration80%
see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 80%
see_also📖Kidney-Brain Neurodegeneration Axis80%
see_also📖Lipid Dysregulation in Neurodegeneration80%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration80%
see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration80%
see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration80%
see_also📖Metal Homeostasis Dysregulation in Neurodegeneration80%
see_also📖Metal Homeostasis in Neurodegeneration80%
see_also📖Microglial Priming Pathway in Neurodegeneration80%
see_also📖MicroRNA Dysfunction in Neurodegeneration80%
see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration80%
see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration80%
see_also📖Mitochondrial Fusion in Neurodegeneration80%
see_also📖Molecular Chaperones in Neurodegeneration80%
see_also📖mTOR Signaling in Neurodegeneration80%
see_also📖mTOR Signaling Pathway in Neurodegeneration80%
see_also📖Neural Circuit Disruption in Neurodegeneration80%
see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N80%
see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati80%
see_also📖Neuronal Hyperexcitability in Neurodegeneration80%
see_also📖Neuropil Threads in Neurodegeneration80%
see_also📖Neurotensin Signaling in Neurodegeneration80%
see_also📖Neurovascular Unit Dysfunction in Neurodegeneration80%
see_also📖NF-kB Signaling Pathway in Neurodegeneration80%
see_also📖Nitric Oxide Signaling in Neurodegeneration80%
see_also📖Noradrenergic Signaling Pathway in Neurodegeneration80%
see_also📖Neuropeptide Y Signaling in Neurodegeneration80%
see_also📖NRF2 Signaling Pathway in Neurodegeneration80%
see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration80%
see_also📖Orexin Signaling in Neurodegeneration80%
see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration80%
see_also📖P-Body (Processing Body) Pathway in Neurodegeneration80%
see_also📖Paranodal Dysfunction in Neurodegeneration80%
see_also📖Paraptosis in Neurodegeneration80%
see_also📖Parthanatos in Neurodegeneration80%
see_also📖Pericyte Loss in Neurodegeneration80%
see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration80%
see_also📖PKR Pathway in Neurodegeneration80%
see_also📖PPAR Signaling Pathway in Neurodegeneration80%
see_also📖Prion Diseases in Neurodegeneration80%
see_also📖Prion-Like Spread in Neurodegeneration80%
see_also📖Prion Protein Metabolism in Neurodegeneration80%
see_also📖Progesterone Signaling Pathway in Neurodegeneration80%
see_also📖Prognostic Biomarkers in Neurodegeneration80%
see_also📖Protein Aggregation Comparison in Neurodegeneration80%
see_also📖Protein Aggregation Seeds in Neurodegeneration80%
see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration80%
see_also📖Cortical Involvement and Neurodegeneration in Progressive Su80%
see_also📖Purinergic Signaling in Neurodegeneration80%
see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener80%
see_also📖R-Loop Stress in Neurodegeneration80%
see_also📖RAN Translation in Neurodegeneration80%
see_also📖Retinal Degeneration Pathway in Neurodegeneration80%
see_also📖Ribosome Dysfunction in Neurodegeneration80%
see_also📖RNA Splicing in Neurodegeneration80%
see_also📖RNA-Targeted Therapies in Neurodegeneration80%
see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a80%
see_also📖S100 Protein Signaling Pathway in Neurodegeneration80%
see_also📖Senescent Cell Clearance in Neurodegeneration80%
see_also📖Serotonergic Dysfunction in Neurodegeneration80%
see_also📖Sex Differences in Neurodegeneration80%
see_also📖Short Chain Fatty Acids in Neurodegeneration80%
see_also📖Sigma-1 Receptor Signaling in Neurodegeneration80%
see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration80%
see_also📖Sleep Dysfunction in Neurodegeneration80%
see_also📖SUMOylation in Neurodegeneration80%
see_also📖synaptic-vesicle-cycling-neurodegeneration80%
see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration80%
see_also📖T-Cell Dysfunction in Neurodegeneration80%
see_also📖Tertiary Lymphoid Organs in Neurodegeneration80%
see_also📖Therapeutic Targets in Neurodegeneration80%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration80%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration80%
see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration80%
see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration80%
see_also📖Vagus Nerve Pathway in Neurodegeneration80%
see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio80%
see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio80%
see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen80%
see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration80%
see_also📖Neuroimaging for Parkinsonian Syndromes (NCT03872102)80%
see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease80%
see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE75%
see_also📖UPenn Observational Research Repository (NCT04715399)75%
related🧫Cytochrome Therapeutics70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Cytochrome Therapeutics70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
see_also📖APOE4 (Apolipoprotein E4)70%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna69%
mentions🧪Vagal Afferent Microbial Signal Modulation68%
see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 65%
see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial65%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St65%
see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739265%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime65%
mentions🧪Vocal Cord Neuroplasticity Stimulation63%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna62%
related🧪Vagal Afferent Microbial Signal Modulation61%
see_also📖CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD60%
see_also📖MK-1167 Phase 2 AD Trial (MK-1167-008)60%
see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M60%
see_also📖nct0550878960%
see_also📖PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical AD60%
see_also📖remternetug-anti-amyloid-alzheimers60%
see_also📖APOE2 (Apolipoprotein E2)60%
see_also📖APOE3 (Apolipoprotein E3)60%
see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas60%
see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc60%
see_also📖SNCA Gene Variants and Mutations60%
see_also📖SNCA — Alpha-Synuclein Gene Entity Page60%
see_also📖PSP Liquid-Liquid Phase Separation and Biomolecular Condensa60%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur60%
related🧫s:** - Biochemical binding assays measuring PROTAC selectivi60%
related🧫Proposed experiment from debate on Epigenetic clocks and bio60%
related🧫Proposed experiment from debate on Microglia activate astroc60%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur60%
related🧫Proposed experiment from debate on Epigenetic clocks and bio60%
related🧫s:** - Temporal analysis showing mitochondrial defects prece60%
related🧫s:** - Test MCU overexpression specifically in layer II neur60%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l60%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l60%
related🧫s:** - Compare uptake with/without magnetic particles using 60%
related🧫Proposed experiment from debate on Perivascular spaces and g60%
related🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice60%
related🧫Proposed experiment from debate on Mitochondrial transfer be60%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional60%
related🧫Proposed experiment from debate on Perivascular spaces and g60%
related🧫Proposed experiment from debate on Mitochondrial transfer be60%
related🧫s:** - Dose-response studies showing therapeutic window with60%
related🧫Proposed experiment from debate on Senolytics targeting p16/60%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy60%
related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka60%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi60%
related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr60%
related🧫DLB Cognitive Fluctuation Mechanism Experiment60%
related🧫Genetic Risk Modifiers in DLB Phenotype60%
related🧫Tau Co-Pathology in DLB Clinical Heterogeneity60%
related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras60%
related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 60%
related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P60%
related🧫Epigenetic Dysregulation in Huntington's Disease — Ther60%
related🧫Experiment Index60%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M60%
related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin60%
related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment60%
related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design60%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre60%
related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 60%
related🧫NPH Glymphatic System Interaction Experiment60%
related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G60%
related🧫Prion Strain Diversity and Selective Vulnerability in CJD60%
related🧫Protein Aggregation Kinetic Validation Results60%
related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel60%
related🧫Experiment Scoring Methodology60%
related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec60%
related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati60%
related🧫Tau Pathology Initiation Zone Identification60%
related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo60%
related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro60%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in60%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal60%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an60%
related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 60%
related🧪Vocal Cord Neuroplasticity Stimulation56%
see_also📖Long-term Effects of Hearing Intervention on Brain Health in55%
see_also📖Multimodal Diagnostic Algorithm for CBS and PSP55%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur54%
related🧫s:** - Biochemical binding assays measuring PROTAC selectivi54%
related🧫Proposed experiment from debate on Epigenetic clocks and bio54%
related🧫Proposed experiment from debate on Microglia activate astroc54%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur54%
related🧫Proposed experiment from debate on Epigenetic clocks and bio54%
related🧫s:** - Temporal analysis showing mitochondrial defects prece54%
related🧫s:** - Test MCU overexpression specifically in layer II neur54%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l54%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l54%
related🧫s:** - Compare uptake with/without magnetic particles using 54%
related🧫Proposed experiment from debate on Perivascular spaces and g54%
related🧫s:** - Test tau spreading in AQP4 knockout vs wild-type mice54%
related🧫Proposed experiment from debate on Mitochondrial transfer be54%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional54%
related🧫Proposed experiment from debate on Perivascular spaces and g54%
related🧫Proposed experiment from debate on Mitochondrial transfer be54%
related🧫s:** - Dose-response studies showing therapeutic window with54%
related🧫Proposed experiment from debate on Senolytics targeting p16/54%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy54%
related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka54%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi54%
related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr54%
related🧫DLB Cognitive Fluctuation Mechanism Experiment54%
related🧫Genetic Risk Modifiers in DLB Phenotype54%
related🧫Tau Co-Pathology in DLB Clinical Heterogeneity54%
related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras54%
related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 54%
related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P54%
related🧫Epigenetic Dysregulation in Huntington's Disease — Ther54%
related🧫Experiment Index54%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M54%
related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin54%
related🧫Iron Dyshomeostasis in MSA Pathogenesis Experiment54%
related🧫Levodopa-Induced Dyskinesias Mechanism — Experiment Design54%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre54%
related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 54%
related🧫NPH Glymphatic System Interaction Experiment54%
related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G54%
related🧫Prion Strain Diversity and Selective Vulnerability in CJD54%
related🧫Protein Aggregation Kinetic Validation Results54%
related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel54%
related🧫Experiment Scoring Methodology54%
related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec54%
related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati54%
related🧫Tau Pathology Initiation Zone Identification54%
related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo54%
related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro54%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in54%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal54%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an54%
related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 54%
mentions🧪Temporal Decoupling via Circadian Clock Reset50%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
mentions🧪Netrin-1 Gradient Restoration50%
mentions🧪Smartphone-Detected Motor Variability Correction50%
mentions🧪Purinergic Signaling Polarization Control50%
mentions🧪Mitochondrial-Lysosomal Contact Site Engineering50%
mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 50%
mentions🧪Circadian-Synchronized Proteostasis Enhancement50%
mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪Mitochondrial SPM Synthesis Platform Engineering50%
mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%
mentions🧪Senescent Cell Mitochondrial DNA Release50%
mentions🧪SASP-Mediated Cholinergic Synapse Disruption50%
mentions🧪Mitochondrial RNA Granule Rescue Pathway50%
mentions🧪Multi-Modal Stress Response Harmonization50%
mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%
mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade50%
mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%
mentions🧪Retinal Vascular Microcirculation Rescue50%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%
mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho50%
mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%
mentions🧪Noradrenergic-Tau Propagation Blockade50%
mentions🧪Adenosine-Astrocyte Metabolic Reset50%
mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors50%
mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists50%
mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%
mentions🧪Quantum Coherence Disruption in Cellular Communication50%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
mentions🧪Cryptic Exon Silencing Restoration50%
mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics50%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%
mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%
mentions🧪SASP-Mediated Complement Cascade Amplification50%
mentions🧪Complement C1q Subtype Switching50%
mentions🧪Microglial Purinergic Reprogramming50%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%
mentions🧪Autophagosome Maturation Checkpoint Control50%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement50%
mentions🧪Sphingolipid Metabolism Reprogramming50%
mentions🧪Low Complexity Domain Cross-Linking Inhibition50%
mentions🧪Ocular Immune Privilege Extension50%
mentions🧪Gut Barrier Permeability-α-Synuclein Axis Modulation50%
mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%
mentions🧪Extracellular Matrix Stiffness Modulation50%
mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%
mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%
mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
mentions🧪Senescence-Induced Lipid Peroxidation Spreading50%
mentions🧪Piezoelectric Nanochannel BBB Disruption50%
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis50%
mentions🧪Lipid Droplet Dynamics as Phenotype Switches50%
mentions🧪Circadian-Synchronized LRP1 Pathway Activation50%
mentions🧪Glycine-Rich Domain Competitive Inhibition50%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%
mentions🧪Axonal RNA Transport Reconstitution50%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%
mentions🧪Circadian-Gated Maresin Biosynthesis Amplification50%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%
mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation50%
mentions🧪Lysosomal Membrane Repair Enhancement50%
mentions🧪Sleep Spindle-Synaptic Plasticity Enhancement50%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%
mentions🧪Blood-Brain Barrier SPM Shuttle System50%
mentions🧪Mitochondrial Transfer Pathway Enhancement50%
mentions🧪Stress Granule Phase Separation Modulators50%
mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Pharmacological Enhancement of APOE4 Glycosylation50%
mentions🧪Membrane Cholesterol Gradient Modulators50%
mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%
mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu50%
mentions🧪Flotillin-1 Stabilization Compounds50%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
mentions🧪HDAC3-Selective Inhibition for Clock Reset50%
mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati50%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
mentions🧪Transcriptional Autophagy-Lysosome Coupling50%
mentions🧪Digital Twin-Guided Metabolic Reprogramming50%
mentions🧪Lysosomal Positioning Dynamics Modulation50%
mentions🧪Lysosomal Enzyme Trafficking Correction50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides50%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%
mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%
mentions🧪Senescence-Associated Myelin Lipid Remodeling50%
mentions🧪Aquaporin-4 Polarization Rescue50%
mentions🧪Senescence-Activated NAD+ Depletion Rescue50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪Epigenetic Memory Erasure via TET2 Activation50%
mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol50%
mentions🧪Mechanosensitive Ion Channel Reprogramming50%
mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%
mentions🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme50%
mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors50%
mentions🧪Ephrin-B2/EphB4 Axis Manipulation50%
mentions🧪Microbial Inflammasome Priming Prevention50%
mentions🧪Phase-Separated Organelle Targeting50%
mentions🧪Nucleolar Stress Response Normalization50%
mentions🧪Cross-Seeding Prevention Strategy50%
mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution50%
mentions🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection50%
mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat50%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%
mentions🧪Sphingomyelin Synthase Activators for Raft Remodeling50%
mentions🧪RNA Granule Nucleation Site Modulation50%
mentions🔬What are the mechanisms underlying selective vulnerability o50%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
mentions🔬What are the mechanisms underlying apoe4 structural biology 50%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
mentions🔬What are the mechanisms underlying neuroinflammation resolut50%
mentions🔬What are the mechanisms underlying what are the mechanisms b50%
mentions🔬What are the mechanisms underlying rna binding protein dysre50%
mentions🔬What are the mechanisms underlying synaptic pruning by micro50%
mentions🔬What are the mechanisms underlying mitochondrial transfer be50%
mentions🔬What are the mechanisms underlying perivascular spaces and g50%
mentions🔬Epigenetic reprogramming in aging neurons50%
mentions🔬Extracellular vesicle biomarkers for early AD detection50%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
mentions🔬Senescent cell clearance as neurodegeneration therapy50%
mentions🔬Investigate prion-like spreading of tau pathology through co50%
mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio50%
mentions🧫tACS Connectivity Trial in Early Alzheimer's50%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design50%
mentions🧪Ganglioside Rebalancing Therapy50%
mentions🧪Arginine Methylation Enhancement Therapy50%
mentions🧪Complement C1q Mimetic Decoy Therapy50%
mentions🧪CYP46A1 Overexpression Gene Therapy50%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%
mentions🧪PARP1 Inhibition Therapy50%
mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%
mentions🧪Orexin-Microglia Modulation Therapy50%
mentions🧪Lysosomal Calcium Channel Modulation Therapy50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
mentions🧪R-Loop Resolution Enhancement Therapy50%
mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%
mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%
mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Extracellular vesicle biomarkers for early AD detection50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬Analyze the spectrum of microglial activation states (DAM, h50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Senescent cell clearance as neurodegeneration therapy50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
see_also📖p-Tau Biomarker in Immunoglobulin Light Chain and Transthyre50%
see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh50%
see_also📖al002-trem2-agonist-alzheimers50%
see_also📖Digital Therapeutic Platform for Swallowing and Drooling Pro50%
see_also📖Utilisation of Health Services and Quality of Life in Atypic50%
see_also📖Phase 3 Study to Compare the Efficacy and Safety of Masitini50%
see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month50%
see_also📖A Multicenter, Phase III, Randomized, Double Blind, Placebo-50%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 50%
see_also📖A 6-month & 18-month Prospective, Randomized, Placebo-co50%
see_also📖PCDH19-Related Epilepsy (EFMR) — Preclinical Gene Therapy Pr50%
see_also📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi50%
see_also📖CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subc50%
see_also📖Hereditary Sensory and Autonomic Neuropathy (HSAN)50%
see_also📖MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acid50%
see_also📖Mirror Therapy and Sensory Re-education in Corticobasal Synd50%
see_also📖Physical and Occupational Therapy in Corticobasal Syndrome50%
see_also📖Healthcare Economics and Cost of Illness in Progressive Supr50%
see_also📖PSP and Idiopathic Normal Pressure Hydrocephalus: Clinical O50%
see_also📖Rigidity in Corticobasal Syndrome50%
see_also📖Speech Therapy and Communication Aids in Corticobasal Syndro50%
see_also📖Shared Mechanisms Between Alzheimer and Parkinson Disease50%
see_also📖APOE4 and Alzheimer's Disease Risk50%
see_also📖Blood-Brain Barrier and Neuroimmune Interface in CBS/PSP50%
see_also📖Blood-Brain Barrier Dysfunction and Therapeutic Delivery for50%
see_also📖Braak Staging and Tau Propagation Pathway50%
see_also📖CBS/PSP Panxoneopathy and Membrane Biology50%
see_also📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise50%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t50%
see_also📖Glial Tau Pathology in PSP and CBD50%
see_also📖Glymphatic Clearance Hypothesis — Impaired Aβ and Tau Remova50%
see_also📖Glymphatic and Vascular Clearance Dysfunction in 4R-Tauopath50%
see_also📖Neuroinflammation in Parkinson's Disease Dementia and D50%
see_also📖Pesticides and Parkinson Disease (Pest-PD) — NCT0642031050%
see_also📖Metabolic Dysfunction and Insulin Resistance in Progressive 50%
see_also📖Synaptic Loss and Dysfunction Pathway50%
see_also📖Systemic Infection and Tau Pathology Acceleration50%
see_also📖Tau Seeding and Propagation Pathway50%
see_also📖ALS Therapeutic Landscape — Programs by Phase and Modality50%
see_also📖AAIC 2026: Tau-PET Imaging and Fluid Biomarker Integration45%
see_also📖Alpha-Synuclein PET Imaging and Biomarker Advances45%
see_also📖Alpha-Synuclein Seeding Assays (RT-QuIC and PMCA)45%
see_also📖Aquaporin-4 (AQP4) - Glymphatic System Biomarker45%
see_also📖Imaging Biomarkers for Corticobasal Syndrome and Progressive45%
see_also📖Multi-Analyte Biomarker Panel for Parkinson's Disease D45%
see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease45%
see_also📖Polygenic Risk Score Integration Panel for Alzheimer's 45%
see_also📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy45%
see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease45%
see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers45%
see_also📖BLAAC PD - Black and African Americans Connections to PD (NC45%
see_also📖Clostridium Butyricum for Motor and Non-motor Symptoms in Pa45%
see_also📖CNversyt and Megan Rodden ALS Trials45%
see_also📖Cognitive and Speech Rehabilitation in CBS (NCT05823421)45%
see_also📖DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat45%
see_also📖Donanemab TRAILBLAZER-ALZ 2 Trial45%
see_also📖First-in-Human 4R Tau Ligand Study in PSP (NCT07348276)45%
see_also📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo45%
see_also📖Gait and Upper Limb Evaluation in PSP (NCT07136844)45%
see_also📖GBA Brain Molecular Imaging and Blood Biomarkers for Precisi45%
see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime45%
see_also📖Safety and Clinical Outcomes Study: Amniotic and Umbilical C45%
see_also📖A Phase III, Randomized, Double-Blind, Placebo-Controlled, M45%
see_also📖A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-C45%
see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di45%
see_also📖A Phase 3, Randomized, Double-blind, Placebo-controlled, Par45%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%
see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451645%
see_also📖Whole-Body Photobiomodulation for Motor and Cognitive Change45%
see_also📖Quality of Life and Caregiver Burden in PSP (NCT03638505)45%
see_also📖Silymarin for Neuroprotection and Symptom Management in Park45%
see_also📖Social Behaviors and Quality of Life in Parkinson's Dis45%
see_also📖Clinical Efficacy and Mechanism of tDCS for Dysphagia in Par45%
see_also📖Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT0717045%
see_also📖UB-311 Alzheimer's Vaccination Trial45%
see_also📖alexander-disease45%
see_also📖Alexander Disease Genetic Variants45%
see_also📖ATP13A9 and Parkinson's Disease45%
see_also📖Callosal Disconnection and Interhemispheric Dysfunction in C45%
see_also📖Caregiver Burden and Support in Corticobasal Syndrome45%
see_also📖Caregiver Support and Palliative Care in Atypical [Parkinson45%
see_also📖Clinical Phenotypes and Subtypes of Corticobasal Syndrome45%
see_also📖Natural History and Prognosis of Corticobasal Syndrome45%
see_also📖Dysphagia and Nutritional Management in Corticobasal Syndrom45%
see_also📖Environmental Toxins and Parkinson's Risk45%
see_also📖HIV-Associated Neurocognitive Disorders (HAND)45%
see_also📖Hemiballismus and Hemichorea in Corticobasal Syndrome45%
see_also📖Investment Landscape: ALS45%
see_also📖Investment Landscape: Frontotemporal Dementia45%
see_also📖Investment Landscape: Huntington's Disease45%
see_also📖Investment Landscape: Parkinson's Disease45%
see_also📖Japanese and German Case Series in Corticobasal Degeneration45%
see_also📖Jervell and Lange-Nielsen Syndrome45%
see_also📖LRRK2 Gene Variants and Mutations45%
see_also📖Nutritional Support and Dietary Interventions in Corticobasa45%
see_also📖Postural Dysfunction and Abnormalities in Corticobasal Syndr45%
see_also📖Pseudobulbar Affect and Emotional Lability in Corticobasal S45%
see_also📖Quality of Life and Caregiver Burden in Progressive Supranuc45%
see_also📖Speech and Voice Disorders in PSP45%
see_also📖Sandhoff Disease45%
see_also📖Sialorrhea and Drooling in Corticobasal Syndrome45%
see_also📖Simultanagnosia and Balint's Syndrome in Corticobasal S45%
see_also📖SNCA A53T45%
see_also📖TARDBP Mutations in Amyotrophic Lateral Sclerosis45%
see_also📖Vocational Rehabilitation and Driving in Corticobasal Syndro45%
see_also📖Voice and Speech in Corticobasal Syndrome45%
see_also📖ABCA7 Lipid Transport and Microglial Phagocytosis AD Causal 45%
see_also📖ALS Biomarkers and Disease Monitoring45%
see_also📖C9orf72 Repeat Expansions in CBS and PSP45%
see_also📖Myoclonus and Cortical Hyperexcitability in Corticobasal Syn45%
see_also📖VEGF and Angiogenesis Dysregulation in CBS/PSP45%
see_also📖Pupillometry and Chromatic Pupillometry in Corticobasal Synd45%
see_also📖FTDP-17 Clinical Phenotypes and Disease Progression45%
see_also📖FTLD-TDP Subtypes and Mechanisms45%
see_also📖Iron and Neuromelanin Accumulation in PSP45%
see_also📖LRRK2 Kinase Activation and Endolysosomal Dysfunction in Par45%
see_also📖MSA Clinical Features and Diagnosis45%
see_also📖mTOR Signaling in Autophagy and Lysosomal Function45%
see_also📖Neuroresilience Mechanisms and Evidence45%
see_also📖NLRP3 Inflammasome Inhibitors for Parkinson's Disease45%
see_also📖NLRP3 Inhibitors in Parkinson's Disease: Research and C45%
see_also📖Advanced Proteolysis and Ubiquitin System Targeting in CBS/P45%
see_also📖Gait and Balance Disorders in Progressive Supranuclear Palsy45%
see_also📖HLA Haplotypes and Neuroinflammatory Profiles in PSP45%
see_also📖PSP Lysosomal Dysfunction and Autophagy Impairment45%
see_also📖Pupillary and Visual Dysfunction in Progressive Supranuclear45%
see_also📖PSP Tau Propagation and Spreading Mechanisms45%
see_also📖PSP Weight Loss and Cachexia45%
see_also📖Sleep Architecture Changes in CBS and PSP45%
see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease45%
see_also📖Somatic Mutations and Brain Mosaicism45%
see_also📖Speech and Language Deficits in Corticobasal Syndrome45%
see_also📖TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain45%
mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise44%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt40%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross40%
mentions🔬What are the mechanisms underlying digital biomarkers and ai40%
mentions🔬What are the mechanisms underlying mechanistic role of apoe 40%
mentions🔬Investigate how lipid raft composition (cholesterol metaboli40%
mentions🔬What are the mechanisms underlying sleep disruption as cause40%
mentions🔬What are the mechanisms underlying epigenetic clocks and bio40%
mentions🔬Analyze circuit-level changes in neurodegeneration using All40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬Analyze the spectrum of microglial activation states (DAM, h40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
mentions🔬What are the mechanisms underlying senolytic therapy for age40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
related🧪Temporal Decoupling via Circadian Clock Reset40%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination40%
related🧪Netrin-1 Gradient Restoration40%
related🧪Smartphone-Detected Motor Variability Correction40%
related🧪Purinergic Signaling Polarization Control40%
related🧪Mitochondrial-Lysosomal Contact Site Engineering40%
related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 40%
related🧪Circadian-Synchronized Proteostasis Enhancement40%
related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration40%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement40%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%
related🧪Ganglioside Rebalancing Therapy40%
related🧪Mitochondrial SPM Synthesis Platform Engineering40%
related🧪CX43 hemichannel engineering enables size-selective mitochon40%
related🧪Arginine Methylation Enhancement Therapy40%
related🧪Senescent Cell Mitochondrial DNA Release40%
related🧪SASP-Mediated Cholinergic Synapse Disruption40%
related🧪Mitochondrial RNA Granule Rescue Pathway40%
related🧪Multi-Modal Stress Response Harmonization40%
related🧪Complement C1q Mimetic Decoy Therapy40%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu40%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc40%
related🧪CYP46A1 Overexpression Gene Therapy40%
related🧪Enteric Nervous System Prion-Like Propagation Blockade40%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%
related🧪Retinal Vascular Microcirculation Rescue40%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition40%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho40%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation40%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%
related🧪Noradrenergic-Tau Propagation Blockade40%
related🧪Adenosine-Astrocyte Metabolic Reset40%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones40%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors40%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists40%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations40%
related🧪Quantum Coherence Disruption in Cellular Communication40%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%
related🧪Cryptic Exon Silencing Restoration40%
related🧪SIRT6-NAD+ Axis Enhancement Therapy40%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics40%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes40%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%
related🧪SASP-Mediated Complement Cascade Amplification40%
related🧪Complement C1q Subtype Switching40%
related🧪Microglial Purinergic Reprogramming40%
related🧪Heat Shock Protein 70 Disaggregase Amplification40%
related🧪Autophagosome Maturation Checkpoint Control40%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal40%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement40%
related🧪Sphingolipid Metabolism Reprogramming40%
related🧪PARP1 Inhibition Therapy40%
related🧪Low Complexity Domain Cross-Linking Inhibition40%
related🧪Ocular Immune Privilege Extension40%
related🧪Hypocretin-Neurogenesis Coupling Therapy40%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation40%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu40%
related🧪Extracellular Matrix Stiffness Modulation40%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism40%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation40%
related🧪Perforant Path Presynaptic Terminal Protection Strategy40%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor40%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset40%
related🧪Senescence-Induced Lipid Peroxidation Spreading40%
related🧪Piezoelectric Nanochannel BBB Disruption40%
related🧪Lipid Droplet Dynamics as Phenotype Switches40%
related🧪Circadian-Synchronized LRP1 Pathway Activation40%
related🧪Glycine-Rich Domain Competitive Inhibition40%
related🧪SASP-Driven Aquaporin-4 Dysregulation40%
related🧪Axonal RNA Transport Reconstitution40%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In40%
related🧪Circadian-Gated Maresin Biosynthesis Amplification40%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%
related🧪Orexin-Microglia Modulation Therapy40%
related🧪KDM6A-Mediated H3K27me3 Rejuvenation40%
related🧪Lysosomal Membrane Repair Enhancement40%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement40%
related🧪Lysosomal Calcium Channel Modulation Therapy40%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue40%
related🧪Blood-Brain Barrier SPM Shuttle System40%
related🧪Mitochondrial Transfer Pathway Enhancement40%
related🧪Stress Granule Phase Separation Modulators40%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr40%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction40%
related🧪Pharmacological Enhancement of APOE4 Glycosylation40%
related🧪Membrane Cholesterol Gradient Modulators40%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto40%
related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu40%
related🧪Flotillin-1 Stabilization Compounds40%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy40%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling40%
related🧪HDAC3-Selective Inhibition for Clock Reset40%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati40%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%
related🧪Transcriptional Autophagy-Lysosome Coupling40%
related🧪Digital Twin-Guided Metabolic Reprogramming40%
related🧪Lysosomal Positioning Dynamics Modulation40%
related🧪Lysosomal Enzyme Trafficking Correction40%
related🧪Circadian Clock-Autophagy Synchronization40%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides40%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri40%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai40%
related🧪Senescence-Associated Myelin Lipid Remodeling40%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%
related🧪Glial Glycocalyx Remodeling Therapy40%
related🧪R-Loop Resolution Enhancement Therapy40%
related🧪Aquaporin-4 Polarization Rescue40%
related🧪Senescence-Activated NAD+ Depletion Rescue40%
related🧪Competitive APOE4 Domain Stabilization Peptides40%
related🧪Epigenetic Memory Erasure via TET2 Activation40%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol40%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy40%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy40%
related🧪Mechanosensitive Ion Channel Reprogramming40%
related🧪Serine/Arginine-Rich Protein Kinase Modulation40%
related🧪Selective Acid Sphingomyelinase Modulation Therapy40%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)40%
related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme40%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors40%
related🧪Ephrin-B2/EphB4 Axis Manipulation40%
related🧪Microbial Inflammasome Priming Prevention40%
related🧪Phase-Separated Organelle Targeting40%
related🧪Nucleolar Stress Response Normalization40%
related🧪Cross-Seeding Prevention Strategy40%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution40%
related🧪Purinergic P2Y12 Inverse Agonist Therapy40%
related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection40%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat40%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch40%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming40%
related🧪Sphingomyelin Synthase Activators for Raft Remodeling40%
related🧪RNA Granule Nucleation Site Modulation40%
related🧪APOE Isoform Conversion Therapy35%
related🧪Liquid-Liquid Phase Separation Modifier Therapy35%
related🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding35%
related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy35%
related🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration35%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy35%
related🧪APOE4-Selective Lipid Nanoemulsion Therapy35%
related🔬What are the mechanisms underlying selective vulnerability o30%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp30%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub